Page 7 - Biodesix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation. Earnings & Valuation This table compares Biodesix and AnPac […]

Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Insider & Institutional Ownership 45.8% of AnPac Bio-Medical Science […]

Biodesix (NASDAQ:BDSX – Get Rating) and AnPac Bio-Medical Science (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations. Analyst Ratings This is a summary of current ratings […]

Biodesix (NASDAQ:BDSX – Get Rating) and Invitae (NYSE:NVTA – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Institutional & Insider Ownership 76.8% of Invitae shares are held by […]

28.02.2023 - Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1x1 ...